Therapy-resistent lupus skin disease successfully treated with rituximab
Identifieur interne : 000A22 ( Istex/Corpus ); précédent : 000A21; suivant : 000A23Therapy-resistent lupus skin disease successfully treated with rituximab
Auteurs : A. P. Risselada ; C. G. M. KallenbergSource :
- Rheumatology [ 1462-0324 ] ; 2006.
Url:
DOI: 10.1093/rheumatology/kel162
Links to Exploration step
ISTEX:99F3619D2260645E87E031DE0C7628A771D0C70ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapy-resistent lupus skin disease successfully treated with rituximab</title><author><name sortKey="Risselada, A P" sort="Risselada, A P" uniqKey="Risselada A" first="A. P." last="Risselada">A. P. Risselada</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Kallenberg, C G M" sort="Kallenberg, C G M" uniqKey="Kallenberg C" first="C. G. M." last="Kallenberg">C. G. M. Kallenberg</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:99F3619D2260645E87E031DE0C7628A771D0C70E</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1093/rheumatology/kel162</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000A22</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A22</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Therapy-resistent lupus skin disease successfully treated with rituximab</title><author><name sortKey="Risselada, A P" sort="Risselada, A P" uniqKey="Risselada A" first="A. P." last="Risselada">A. P. Risselada</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Kallenberg, C G M" sort="Kallenberg, C G M" uniqKey="Kallenberg C" first="C. G. M." last="Kallenberg">C. G. M. Kallenberg</name><affiliation><mods:affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Rheumatology</title><title level="j" type="abbrev">Rheumatology</title><idno type="ISSN">1462-0324</idno><idno type="eISSN">1462-0332</idno><imprint><publisher>Oxford University Press</publisher><date type="e-published" when="2006-05-11">2006</date><date when="2006-07">2006</date><biblScope unit="vol">45</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="915">915</biblScope><biblScope unit="page" to="916">916</biblScope></imprint><idno type="ISSN">1462-0324</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1462-0324</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><istex><corpusName>oup</corpusName><keywords><teeft><json:string>lupus</json:string><json:string>rituximab</json:string><json:string>prednisolone</json:string><json:string>erythematosus</json:string><json:string>cutaneous</json:string><json:string>rheumatology</json:string><json:string>azathioprine</json:string><json:string>neuromyelitis</json:string><json:string>dermatol</json:string><json:string>mycophenolate</json:string><json:string>mofetil</json:string><json:string>skin manifestation</json:string><json:string>skin lesion</json:string><json:string>lupus skin disease</json:string><json:string>optica</json:string><json:string>mycophenolate mofetil</json:string><json:string>neuromyelitis optica</json:string><json:string>immunosuppressive</json:string><json:string>thalidomide</json:string><json:string>cyclophosphamide</json:string><json:string>groningen</json:string><json:string>systemic lupus erythematosus</json:string><json:string>relapse</json:string><json:string>monoclonal</json:string><json:string>autoimmune</json:string><json:string>successful treatment</json:string><json:string>arthritis rheum</json:string><json:string>clinical immunology</json:string><json:string>monoclonal antibody</json:string><json:string>predominant lupus skin disease</json:string><json:string>muscle weakness</json:string><json:string>prednisolone daily</json:string><json:string>lupus nephritis</json:string><json:string>serious adverse event</json:string><json:string>systemic therapy</json:string><json:string>university medical center groningen</json:string><json:string>cutaneous lupus erythematosus</json:string><json:string>refractory</json:string><json:string>rash</json:string></teeft></keywords><author><json:item><name>A. P. Risselada</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</json:string></affiliations></json:item><json:item><name>C. G. M. Kallenberg</name><affiliations><json:string>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</json:string></affiliations></json:item></author><arkIstex>ark:/67375/HXZ-47KXN28S-C</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>other</json:string></originalGenre><qualityIndicators><score>2.769</score><pdfWordCount>1386</pdfWordCount><pdfCharCount>9786</pdfCharCount><pdfVersion>1.5</pdfVersion><pdfPageCount>2</pdfPageCount><pdfPageSize>595 x 791 pts</pdfPageSize><pdfWordsPerPage>693</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>0</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Therapy-resistent lupus skin disease successfully treated with rituximab</title><pmid><json:string>16690759</json:string></pmid><genre><json:string>other</json:string></genre><host><title>Rheumatology</title><language><json:string>unknown</json:string></language><issn><json:string>1462-0324</json:string></issn><eissn><json:string>1462-0332</json:string></eissn><publisherId><json:string>brheum</json:string></publisherId><volume>45</volume><issue>7</issue><pages><first>915</first><last>916</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>2006-05-11</json:string><json:string>1997</json:string><json:string>2006</json:string><json:string>1987</json:string><json:string>1999</json:string><json:string>1989</json:string></date><geogName></geogName><orgName><json:string>University Medical Center Groningen</json:string><json:string>KALLENBERG Department of Rheumatology and Clinical Immunology</json:string><json:string>University Medical Center Groningen, Groningen</json:string><json:string>Department of Rheumatology and Clinical Immunology</json:string><json:string>Netherlands Accepted</json:string><json:string>Department of Pediatrics, Rheumatology Unit, University of Florence, Anna Meyer Children</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>T. Ef</json:string><json:string>L. Devic</json:string><json:string>P.O. Box</json:string><json:string>C. Devic</json:string><json:string>J. Devic</json:string><json:string>B. Mycophenolate</json:string><json:string>C. G. M. Kallenberg</json:string><json:string>C. Mycophenolate</json:string><json:string>Via Pico</json:string></persName><placeName><json:string>Groningen</json:string><json:string>Toxicity</json:string><json:string>Pandorf</json:string><json:string>Metz</json:string><json:string>Florence</json:string><json:string>Cambridge</json:string><json:string>Italy</json:string><json:string>Netherlands</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>July 2005</json:string><json:string>[1]</json:string><json:string>[10]</json:string><json:string>June 2005</json:string><json:string>[8, 9]</json:string><json:string>[5]</json:string><json:string>August 2005</json:string><json:string>[9]</json:string><json:string>September 2005</json:string><json:string>[2]</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/HXZ-47KXN28S-C</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - rheumatology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - arthritis & rheumatology</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pharmacology (medical)</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Rheumatology</json:string></scopus></categories><publicationDate>2006</publicationDate><copyrightDate>2006</copyrightDate><doi><json:string>10.1093/rheumatology/kel162</json:string></doi><id>99F3619D2260645E87E031DE0C7628A771D0C70E</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Therapy-resistent lupus skin disease successfully treated with rituximab</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Oxford University Press</publisher><availability><licence>© The Author [2006]. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</licence></availability><date type="e-published" when="2006-05-11">2006</date><date when="2006-07">2006</date><date type="Copyright" when="2006">2006</date></publicationStmt><notesStmt><note type="content-type" source="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="other"><analytic><title level="a" type="main" xml:lang="en">Therapy-resistent lupus skin disease successfully treated with rituximab</title><author xml:id="author-0000"><persName><surname>Risselada</surname><forename type="first">A. P.</forename></persName><affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</affiliation><affiliation><orgName type="department">Department of Rheumatology and Clinical Immunology</orgName><address><addrLine>University Medical Center Groningen, Groningen, The Netherlands</addrLine><country key="NL" xml:lang="en">NETHERLANDS</country></address></affiliation><affiliation role="corresp">Correspondence to: Prof. Dr C. G. M. Kallenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. E-mail: c.g.m.kallenberg@int.umcg.nl</affiliation></author><author xml:id="author-0001"><persName><surname>Kallenberg</surname><forename type="first">C. G. M.</forename></persName><affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</affiliation><affiliation><orgName type="department">Department of Rheumatology and Clinical Immunology</orgName><address><addrLine>University Medical Center Groningen, Groningen, The Netherlands</addrLine><country key="NL" xml:lang="en">NETHERLANDS</country></address></affiliation><affiliation role="corresp">Correspondence to: Prof. Dr C. G. M. Kallenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. E-mail: c.g.m.kallenberg@int.umcg.nl</affiliation></author><idno type="istex">99F3619D2260645E87E031DE0C7628A771D0C70E</idno><idno type="ark">ark:/67375/HXZ-47KXN28S-C</idno><idno type="other">kel162</idno><idno type="DOI">10.1093/rheumatology/kel162</idno></analytic><monogr><title level="j" type="main">Rheumatology</title><title level="j" type="abbrev">Rheumatology</title><idno type="hwp">rheumatology</idno><idno type="nlm-ta">Rheumatology (Oxford)</idno><idno type="publisher-id">brheum</idno><idno type="pISSN">1462-0324</idno><idno type="eISSN">1462-0332</idno><imprint><publisher>Oxford University Press</publisher><date type="e-published" when="2006-05-11">2006</date><date when="2006-07">2006</date><biblScope unit="vol">45</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="915">915</biblScope><biblScope unit="page" to="916">916</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-09"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><textClass ana="subject"><keywords scheme="heading"><term>CASE REPORTS</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-09" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup, element #text not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="US-ASCII"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article xml:lang="en" article-type="other"><front><journal-meta><journal-id journal-id-type="hwp">rheumatology</journal-id><journal-id journal-id-type="nlm-ta">Rheumatology (Oxford)</journal-id>
<journal-id journal-id-type="publisher-id">brheum</journal-id><journal-title>Rheumatology</journal-title><abbrev-journal-title abbrev-type="publisher">Rheumatology</abbrev-journal-title><issn pub-type="ppub">1462-0324</issn><issn pub-type="epub">1462-0332</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="other">kel162</article-id><article-id pub-id-type="doi">10.1093/rheumatology/kel162</article-id><article-categories><subj-group subj-group-type="heading"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Therapy-resistent lupus skin disease successfully treated with rituximab</article-title></title-group><contrib-group>
<contrib contrib-type="author"><name><surname>Risselada</surname><given-names>A. P.</given-names></name>
</contrib><contrib contrib-type="author"><name><surname>Kallenberg</surname><given-names>C. G. M.</given-names></name>
</contrib><aff>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</aff></contrib-group><author-notes><corresp>Correspondence to: Prof. Dr C. G. M. Kallenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. E-mail: <ext-link xlink:href="c.g.m.kallenberg@int.umcg.nl" ext-link-type="email">c.g.m.kallenberg@int.umcg.nl</ext-link></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>5</month><year>2006</year></pub-date><pub-date pub-type="ppub"><month>July</month><year>2006</year></pub-date><volume>45</volume><issue>7</issue><fpage>915</fpage><lpage>916</lpage><history><date date-type="accepted"><day>4</day><month>4</month><year>2006</year></date></history><permissions><copyright-statement>© The Author [2006]. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</copyright-statement><copyright-year>2006</copyright-year></permissions><custom-meta-wrap><custom-meta><meta-name>hwp-legacy-fpage</meta-name><meta-value>915</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2006</meta-value></custom-meta><custom-meta><meta-name>hwp-legacy-dochead</meta-name><meta-value>LETTER TO THE EDITOR</meta-value></custom-meta></custom-meta-wrap></article-meta></front>
</article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Therapy-resistent lupus skin disease successfully treated with rituximab</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Therapy-resistent lupus skin disease successfully treated with rituximab</title></titleInfo><name type="personal"><namePart type="given">A. P.</namePart><namePart type="family">Risselada</namePart><affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C. G. M.</namePart><namePart type="family">Kallenberg</namePart><affiliation>Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="other" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre><originInfo><publisher>Oxford University Press</publisher><dateIssued encoding="w3cdtf">2006-07</dateIssued><dateCreated encoding="w3cdtf">2006-04-04</dateCreated><copyrightDate encoding="w3cdtf">2006</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><note type="author-notes">Correspondence to: Prof. Dr C. G. M. Kallenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. E-mail: c.g.m.kallenberg@int.umcg.nl</note><relatedItem type="host"><titleInfo><title>Rheumatology</title></titleInfo><titleInfo type="abbreviated"><title>Rheumatology</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">1462-0324</identifier><identifier type="eISSN">1462-0332</identifier><identifier type="PublisherID">brheum</identifier><identifier type="PublisherID-hwp">rheumatology</identifier><identifier type="PublisherID-nlm-ta">Rheumatology (Oxford)</identifier><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>915</start><end>916</end></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB1"><titleInfo><title>Dermatol Clin</title></titleInfo><note>Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin 2002;20:373–85.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>373</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB2"><titleInfo><title>Am J Clin Dermatol</title></titleInfo><note>Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 2003;4:449–65.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>449</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB3"><titleInfo><title>Am J Med</title></titleInfo><note>Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR. Thalidomide for the treatment of resistent cutaneous lupus: efficacy and safety of different therapeutic regimens. Am J Med 2005;118:246–50.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>118</number></detail><extent unit="pages"><start>246</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB4"><titleInfo><title>Br J Dermatol</title></titleInfo><note>Wenzel J, Brahler S, Bauer R, Bieber T, Tuting T. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol 2005;153:157–62.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>153</number></detail><extent unit="pages"><start>157</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB5"><titleInfo><title>Arthritis Rheum</title></titleInfo><note>Silverman GJ, Weisman S. Rituximab therapy and autoimmune disorders, prospects for anti-B cell therapy. Arthritis Rheum 2003;48:1484–92.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1484</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB6"><titleInfo><title>Pedriatr Dermatol</title></titleInfo><note>Kong HH, Prose NS, Ware RE, Hall RP, 3rd. Successful treatment of refractory childhood pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pedriatr Dermatol 2005;22:461–4.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>461</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB7"><titleInfo><title>Br J Dermatol</title></titleInfo><note>Arin MJ, Engbert A, Krieg T, Hunzelmann N. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 2005;153:620–5.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>153</number></detail><extent unit="pages"><start>620</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB8"><titleInfo><title>Arthritis Rheum</title></titleInfo><note>Looney RJ, Anolik JH, Campbell D et al. B cell depletion as a novel treatment for systemic lupus erythematosus, a phase I/II dose-escalation trial of rituximab. Arthritis Rheum 2004;50:2580–9.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>2580</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB9"><titleInfo><title>Rheumatology</title></titleInfo><note>Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology 2005;44:1542–5.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1542</start></extent></part></relatedItem><relatedItem type="references" displayLabel="BIB10"><titleInfo><title>Lupus</title></titleInfo><note>Weide R, Heymanns J, Pandorf A, Köppler H. Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 2003;12:779–82.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>779</start></extent></part></relatedItem><identifier type="istex">99F3619D2260645E87E031DE0C7628A771D0C70E</identifier><identifier type="ark">ark:/67375/HXZ-47KXN28S-C</identifier><identifier type="DOI">10.1093/rheumatology/kel162</identifier><identifier type="local">kel162</identifier><accessCondition type="use and reproduction" contentType="copyright">© The Author [2006]. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</recordContentSource><recordOrigin>Converted from (version 1.2.0) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-12-09</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/record.json</uri></json:item></metadata><covers><json:item><extension>tiff</extension><original>true</original><mimetype>image/tiff</mimetype><uri>https://api.istex.fr/document/99F3619D2260645E87E031DE0C7628A771D0C70E/covers/tiff</uri></json:item></covers><annexes><json:item><extension>gif</extension><original>true</original><mimetype>image/gif</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/annexes.gif</uri></json:item><json:item><extension>jpeg</extension><original>true</original><mimetype>image/jpeg</mimetype><uri>https://api.istex.fr/ark:/67375/HXZ-47KXN28S-C/annexes.jpeg</uri></json:item></annexes><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000A22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:99F3619D2260645E87E031DE0C7628A771D0C70E
|texte= Therapy-resistent lupus skin disease successfully treated with rituximab
}}
| This area was generated with Dilib version V0.6.33. |  |